发明名称 METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS
摘要 FIELD: medicine. ^ SUBSTANCE: method involves determining thyroxin hormone concentration in cerebral metastasis-ill patient blood prior to treatment beginning. Its concentration being found within the limits of 68.0-115.0 nmole/l, 1 to 3 metastatic lesion foci are predicted to be available. The concentration being from 38.0 to 50.0 nmole/l, more than 4 p metastatic lesion foci are predicted to be available. ^ EFFECT: high forecasting accuracy both in primary examination period, and when carrying out treatment. ^ 1 tbl
申请公布号 RU2300109(C2) 申请公布日期 2007.05.27
申请号 RU20050126132 申请日期 2005.08.17
申请人 ROSTOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT FEDERAL'NOGO AGENTSTVA PO ZDRAVOOKHRANENIJU I SOTSIAL'NOMU RAZVITIJU;SIDORENKO JURIJ SERGEEVICH;AJRAPETOV KAREN GEORGIEVICH;KOZLOVA MARGARITA BORISOVNA;KUCHEROVA TAT'JANA IVANOVNA 发明人 SIDORENKO JURIJ SERGEEVICH;AJRAPETOV KAREN GEORGIEVICH;KOZLOVA MARGARITA BORISOVNA;KUCHEROVA TAT'JANA IVANOVNA
分类号 G01N33/74 主分类号 G01N33/74
代理机构 代理人
主权项
地址